Search

Search Results
Results 1341 - 1350 of 6669 for Cancer pain
  • Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Rinvoq intended for persons living in Australia.
  • Drug - 12 Nov 2025
    Consumer Medicine Information (CMI) about Glivec Tablets intended for persons living in Australia.
  • Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Bavencio intended for persons living in Australia.
  • White Paper - 23 Jul 2025
    Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help patients suffering.
  • Drug - 6 Mar 2025
    Consumer Medicine Information (CMI) about Imanib intended for persons living in Australia.
  • Drug - 28 Feb 2025
    Consumer Medicine Information (CMI) about Pfizer Daunorubicin intended for persons living in Australia.
  • News - 24 Feb 2025
    Low-value care-medical tests and procedures that provide little to no benefit to patients-contributes to excess medical spending and both direct and cascading harms to patients.
  • News - 21 Jan 2025
    A new online guide has launched to support and empower people with vulval lichen sclerosus (LS) to learn about the condition, access the right treatment and live more comfortably.
  • News - 6 Jan 2025
    After surgery, pain is expected and often subsides within a few weeks. But for around 20% of patients, persistent pain may continue for months or even years after a procedure, impacting quality of...
  • Drug - 24 Dec 2024
    Consumer Medicine Information (CMI) about DBL Vinblastine intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.